• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定患者不坚持使用外用皮质类固醇治疗银屑病的动机的相对重要性。

Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis.

作者信息

Brown Katherine K, Rehmus Wingfield E, Kimball Alexa B

机构信息

Stanford University School of Medicine, Stanford, California 94305, USA.

出版信息

J Am Acad Dermatol. 2006 Oct;55(4):607-13. doi: 10.1016/j.jaad.2005.12.021. Epub 2006 Jul 13.

DOI:10.1016/j.jaad.2005.12.021
PMID:17010739
Abstract

BACKGROUND

Medication nonadherence is a significant problem in psoriasis. Although previous research has aimed to quantify the prevalence of nonadherence in topical medication users, patient motivations for intentional nonadherence are not fully understood.

OBJECTIVE

Our purpose was to determine the relative importance of factors contributing to nonadherence in topical corticosteroid users with psoriasis.

METHODS

A survey was distributed to psoriasis patients visiting an outpatient clinic.

RESULTS

Among the 53 persons surveyed, medication nonadherence was 40%. Frustration with medication efficacy, inconvenience, and fear of side effects were the most important reasons patients deviated from usage instructions. Subjects who did not receive instructions on topical treatment duration used corticosteroids longer (>8 weeks) than subjects who were instructed (P < .05).

LIMITATIONS

A relatively small sample size prevented trends in demographic predictors of adherence from reaching statistical significance. The patient self-report format has the potential to introduce recall bias.

CONCLUSIONS

Factors contributing to intentional nonadherence, including dissatisfaction with efficacy, inconvenience, and fear of side effects, are the most important patient-identified barriers to appropriate use of topical steroids in psoriasis. Clear patient instructions on the intended steroid treatment duration may reduce adverse effects from overuse.

摘要

背景

药物治疗依从性差是银屑病治疗中的一个重要问题。尽管先前的研究旨在量化局部用药患者中不依从的发生率,但患者故意不依从的动机尚未完全明确。

目的

我们的目的是确定导致银屑病外用皮质类固醇使用者不依从的因素的相对重要性。

方法

对前往门诊就诊的银屑病患者进行了一项调查。

结果

在53名接受调查的患者中,药物治疗不依从率为40%。对药物疗效感到沮丧、不便以及对副作用的恐惧是患者偏离用药说明的最重要原因。未接受局部治疗持续时间指导的受试者使用皮质类固醇的时间(>8周)比接受指导的受试者更长(P<.05)。

局限性

样本量相对较小,使得依从性人口统计学预测因素的趋势未达到统计学显著性。患者自我报告的形式可能会引入回忆偏差。

结论

导致故意不依从的因素,包括对疗效不满意、不便以及对副作用的恐惧,是患者确定的银屑病患者正确使用外用类固醇的最重要障碍。向患者明确说明类固醇的预期治疗持续时间可能会减少过度使用带来的不良反应。

相似文献

1
Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis.确定患者不坚持使用外用皮质类固醇治疗银屑病的动机的相对重要性。
J Am Acad Dermatol. 2006 Oct;55(4):607-13. doi: 10.1016/j.jaad.2005.12.021. Epub 2006 Jul 13.
2
A prospective study of patient adherence to topical treatments: 95% of patients underdose.一项关于患者局部治疗依从性的前瞻性研究:95%的患者用药剂量不足。
J Am Acad Dermatol. 2008 Dec;59(6):975-80. doi: 10.1016/j.jaad.2008.07.039. Epub 2008 Sep 24.
3
Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use.在一项为期8周的银屑病临床试验过程中,局部治疗的依从性会降低:常用的测量局部治疗依从性的方法高估了实际使用情况。
J Am Acad Dermatol. 2004 Aug;51(2):212-6. doi: 10.1016/j.jaad.2004.01.052.
4
Patients with asthma who do not fill their inhaled corticosteroids: a study of primary nonadherence.未使用吸入性糖皮质激素的哮喘患者:一项关于原发性不依从性的研究。
J Allergy Clin Immunol. 2007 Nov;120(5):1153-9. doi: 10.1016/j.jaci.2007.08.020. Epub 2007 Oct 22.
5
Are ointments better than other vehicles for corticosteroid treatment of psoriasis?在银屑病的皮质类固醇治疗中,软膏剂比其他剂型更好吗?
J Drugs Dermatol. 2009 Jun;8(6):570-2.
6
Patients' educational needs about topical treatments for psoriasis.患者对银屑病局部治疗的教育需求。
J Am Acad Dermatol. 2013 Jun;68(6):e163-8. doi: 10.1016/j.jaad.2012.04.016. Epub 2012 Jun 8.
7
Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.影响银屑病局部皮质类固醇治疗联合应用的因素:来自国际银屑病理事会的观点。
J Eur Acad Dermatol Venereol. 2011 Oct;25(10):1130-9. doi: 10.1111/j.1468-3083.2011.04113.x. Epub 2011 May 13.
8
Class I topical corticosteroid use by psoriasis patients in an academic practice.银屑病患者在学术机构中使用I类外用糖皮质激素的情况。
J Dermatolog Treat. 2004 Jul;15(4):235-8. doi: 10.1080/09546630410033745.
9
Disease burden and treatment adherence in psoriasis patients.银屑病患者的疾病负担与治疗依从性
Cutis. 2013 Nov;92(5):258-63.
10
Psoriasis treatment in the United States at the end of the 20th century.20世纪末美国的银屑病治疗
Int J Dermatol. 2006 Apr;45(4):370-4. doi: 10.1111/j.1365-4632.2006.02532.x.

引用本文的文献

1
The Pendulum of Adherence: An Interpretative Phenomenological Analysis of Psoriasis Treatment Discontinuation.依从性的摆锤:银屑病治疗中断的诠释现象学分析
Patient Prefer Adherence. 2025 Jul 5;19:1893-1908. doi: 10.2147/PPA.S525490. eCollection 2025.
2
A Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Phase 2 Study Evaluating the Efficacy and Safety of GN-037 Cream in Patients with Mild-to-Moderate Plaque Psoriasis.一项多中心随机双盲安慰剂对照平行组2期研究,评估GN-037乳膏治疗轻至中度斑块状银屑病患者的疗效和安全性。
Dermatol Ther (Heidelb). 2024 Dec;14(12):3337-3350. doi: 10.1007/s13555-024-01301-1. Epub 2024 Nov 22.
3
Current Insights on Treatment Adherence in Prevalent Dermatological Conditions and Strategies To Optimize Adherence Rates.
常见皮肤病治疗依从性的当前见解及优化依从率的策略
Cureus. 2024 Sep 19;16(9):e69764. doi: 10.7759/cureus.69764. eCollection 2024 Sep.
4
Adherence in Atopic Dermatitis.特应性皮炎的依从性。
Adv Exp Med Biol. 2024;1447:169-190. doi: 10.1007/978-3-031-54513-9_15.
5
Burden of Topical Treatments in Psoriasis and Preferred Criteria of Choice: A Survey-Based Evaluation of Patients in Europe.银屑病局部治疗负担及首选选择标准:基于调查的欧洲患者评估
Dermatol Ther (Heidelb). 2024 Jun;14(6):1497-1514. doi: 10.1007/s13555-024-01132-0. Epub 2024 Mar 8.
6
Patient-Centric Design of Topical Dermatological Medicines.局部用皮肤病药物的以患者为中心的设计
Pharmaceuticals (Basel). 2023 Apr 19;16(4):617. doi: 10.3390/ph16040617.
7
Polyaphron Dispersion Technology, A Novel Topical Formulation and Delivery System Combining Drug Penetration, Local Tolerability and Convenience of Application.聚阿弗龙分散技术,一种结合药物渗透、局部耐受性和应用便利性的新型局部制剂及给药系统。
Dermatol Ther (Heidelb). 2022 Oct;12(10):2217-2231. doi: 10.1007/s13555-022-00794-y. Epub 2022 Sep 1.
8
Enhancing Topical Pharmacotherapy for Acne and Rosacea: Vehicle Choices and Outcomes.增强痤疮和玫瑰痤疮的局部药物治疗:载体选择与疗效
J Clin Aesthet Dermatol. 2022 May;15(5):36-40.
9
Vehicles for Drug Delivery and Cosmetic Moisturizers: Review and Comparison.药物递送载体与化妆品保湿剂:综述与比较
Pharmaceutics. 2021 Nov 26;13(12):2012. doi: 10.3390/pharmaceutics13122012.
10
Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in Psoriasis.载体重要吗?关于银屑病局部治疗依从性的真实世界证据。
Pharmaceutics. 2021 Sep 23;13(10):1539. doi: 10.3390/pharmaceutics13101539.